The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 4-(1-(2-(1H-indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate ID: ALA478141
PubChem CID: 3157599
Max Phase: Preclinical
Molecular Formula: C24H22N2O5
Molecular Weight: 418.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: BAS 8770945 | CHEMBL478141|BAS 8770945|methyl 4-{3-acetyl-4-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl}benzoate|BAS 08770945|SCHEMBL15563841|BDBM50006934|AKOS000570026|AKOS022097037|methyl 4-[3-acetyl-4-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-5-oxo-2H-pyrrol-2-yl]benzoate|AN-465/42126251
Canonical SMILES: COC(=O)c1ccc(C2C(C(C)=O)=C(O)C(=O)N2CCc2c[nH]c3ccccc23)cc1
Standard InChI: InChI=1S/C24H22N2O5/c1-14(27)20-21(15-7-9-16(10-8-15)24(30)31-2)26(23(29)22(20)28)12-11-17-13-25-19-6-4-3-5-18(17)19/h3-10,13,21,25,28H,11-12H2,1-2H3
Standard InChI Key: RYWFTNOOUZJXNY-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
13.6402 0.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6391 -0.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3539 -0.8777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0703 -0.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0675 0.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3521 0.7753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9256 0.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8392 1.5945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0322 1.7659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6198 1.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1721 0.4384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7993 0.9648 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6964 2.5195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4521 2.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2368 1.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2804 2.9537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0008 -0.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6140 -0.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4427 -1.7275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5850 -3.0571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9971 -2.3424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7779 -2.8858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6937 -2.0655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9426 -1.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2751 -2.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3635 -3.0365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1148 -3.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7855 -0.8757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7867 -1.7007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4993 -0.4621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2144 -0.8735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 15 1 0
3 4 2 0
14 16 2 0
11 17 1 0
4 5 1 0
17 18 1 0
2 3 1 0
18 19 1 0
19 23 1 0
8 9 2 0
9 10 1 0
22 20 1 0
20 21 1 0
21 19 2 0
10 11 1 0
11 7 1 0
22 23 2 0
1 7 1 0
23 24 1 0
5 6 2 0
24 25 2 0
10 12 2 0
25 26 1 0
6 1 1 0
26 27 2 0
27 22 1 0
9 13 1 0
4 28 1 0
7 8 1 0
28 29 2 0
8 14 1 0
28 30 1 0
1 2 2 0
30 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 418.45Molecular Weight (Monoisotopic): 418.1529AlogP: 3.48#Rotatable Bonds: 6Polar Surface Area: 99.70Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.71CX Basic pKa: ┄CX LogP: 2.94CX LogD: 2.94Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.60Np Likeness Score: -0.66
References 1. Olla S, Manetti F, Crespan E, Maga G, Angelucci A, Schenone S, Bologna M, Botta M.. (2009) Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors., 19 (5): [PMID:19179076 ] [10.1016/j.bmcl.2009.01.005 ] 2. Zimmerman SS, Khatri A, Garnier-Amblard EC, Mullasseril P, Kurtkaya NL, Gyoneva S, Hansen KB, Traynelis SF, Liotta DC.. (2014) Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators., 57 (6): [PMID:24512267 ] [10.1021/jm401695d ] 3. (2014) NMDA receptor modulators and uses related thereto,